Shares of IXICO plc (LON:IXI – Get Free Report) traded up 16.7% during mid-day trading on Monday. The company traded as high as GBX 15 and last traded at GBX 14. 2,359,474 shares changed hands during mid-day trading, an increase of 1,836% from the average session volume of 121,868 shares. The stock had previously closed at GBX 12.
IXICO Stock Up 16.7%
The firm has a market cap of £30.66 million, a P/E ratio of -7.18, a price-to-earnings-growth ratio of -0.38 and a beta of 0.11. The company has a current ratio of 2.83, a quick ratio of 4.90 and a debt-to-equity ratio of 5.22. The firm’s 50 day moving average is GBX 8.21 and its two-hundred day moving average is GBX 8.28.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Featured Stories
- Five stocks we like better than IXICO
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
